
C. Ola Landgren/X
Jun 22, 2024, 04:41
C. Ola Landgren: How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape.
Summary of Latest News From ASCO24 Focusing on Newly Diagnosed Myeloma Therapy.
Watch here.”
Source: C. Ola Landgren/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 31, 2025, 13:37
Mar 31, 2025, 12:35
Mar 31, 2025, 12:30
Mar 31, 2025, 12:28